Skip to main content

and
  1. No Access

    Article

    Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study

    Capecitabine–Temozolomide (CapTem) is an oral chemotherapy regimen for NETs. Both drugs are radiosensitizers. Integrating CapTem and Y90 transarterial radioembolization (TARE) in patients with grade 2 neuroend...

    Michael C. Soulen, Ursina R. Teitelbaum in CardioVascular and Interventional Radiology (2024)